BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)

LAHORE: Nearly 34.5 million people are living with diabetes, while around 38 million live with obesity in Pakistan, significantly impacting individuals, families, communities and healthcare system.

Novo Nordisk Pakistan marked a significant milestone in its commitment to shaping the future of healthcare in Pakistan by leading a delegation of key stakeholders to Copenhagen, Denmark. The delegation included representatives from government bodies, healthcare associations and policy decision-making forums.

The Knowledge Exchange initiative was a pioneering effort, reflecting Novo Nordisk’s commitment to working alongside healthcare professionals to drive meaningful and lasting improvements to people living with serious chronic diseases such as diabetes and obesity.

The program provided participants exposure to Denmark’s advanced healthcare ecosystem, allowing the delegation to witness and explore innovative approaches for tackling diabetes and obesity, with an emphasis on early interventions and improved patient care. The visitors engaged in dialogue centred on practical pathways to localize these learning, enabling their adaptation to Pakistan’s unique healthcare needs to drive better patient outcomes and support system-level reforms.

Rashid Rafique Butt, General Manager of Novo Nordisk Pakistan, emphasizing the urgent need for action said: “Diabetes and obesity are among the fastest-growing health challenges in the country, and healthcare professionals are central to addressing them. Through this collaboration, we aimed to empower healthcare professionals with insights and tools to elevate standards of care, secure long-term health, and create healthier communities. This initiative underscores our enduring commitment and confidence to driving change in Pakistan through innovation and sustainable solutions that support the country’s healthcare system and shape its future.”

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.